Results 271 to 280 of about 183,256 (304)
Some of the next articles are maybe not open access.
Journal of Clinical Oncology, 2019
e17050 Background: The majority of OC cases are sporadic, but it is estimated that in 17%, germline mutations in BRCA1 or BRCA2 genes can be identified. BRCA mutated OC has distinct clinical characteristics, increased sensitivity to platinum and non-platinum agents, and to DNA damage repair (DDR) targeting agents like PARP inhibitors.
Susana Beatriz Goncalves +4 more
openaire +1 more source
e17050 Background: The majority of OC cases are sporadic, but it is estimated that in 17%, germline mutations in BRCA1 or BRCA2 genes can be identified. BRCA mutated OC has distinct clinical characteristics, increased sensitivity to platinum and non-platinum agents, and to DNA damage repair (DDR) targeting agents like PARP inhibitors.
Susana Beatriz Goncalves +4 more
openaire +1 more source
Journal of Heart and Vasculature, 2023
Background: introduction of the poly (ADP-ribose) polymerase (PARP) inhibitors to clinical practice remarkably improved outcomes for advanced epithelial ovarian cancer (EOC) patients. We conducted this study to evaluate efficacy of frontline maintenance olaparib therapy in BRCA-mutated and/or HRD-positive EOC patients in real-world practice setting ...
openaire +1 more source
Background: introduction of the poly (ADP-ribose) polymerase (PARP) inhibitors to clinical practice remarkably improved outcomes for advanced epithelial ovarian cancer (EOC) patients. We conducted this study to evaluate efficacy of frontline maintenance olaparib therapy in BRCA-mutated and/or HRD-positive EOC patients in real-world practice setting ...
openaire +1 more source
Blood
Abstract Background: The synergistic mechanisms of BCL-2 inhibitors and CD20-directed antibodies in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) often lead to deep and durable responses.
Lauren Pomerantz +22 more
openaire +1 more source
Abstract Background: The synergistic mechanisms of BCL-2 inhibitors and CD20-directed antibodies in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) often lead to deep and durable responses.
Lauren Pomerantz +22 more
openaire +1 more source
“Eroding trust in the state and in frontline workers can become a catalyst for the rise of populism”
Gabriela Spanghero Lotta, Professor of Public Administration and Government at Getulio Vargas Foundation (FGV) in São Paulo, Brazil, gives a Special Lecture at the IAB on 5 February 2024. In this accompanying interview, Lotta explores the dynamics of citizen-state interactions in Latin America, outlines the role of frontline workers in dealing with ...openaire +1 more source
Journal of Clinical Oncology, 2011
8081 Background: MM is clinically heterogeneous and risk stratification is vital for prognostication and informing treatment.
D. C. Tan +7 more
openaire +1 more source
8081 Background: MM is clinically heterogeneous and risk stratification is vital for prognostication and informing treatment.
D. C. Tan +7 more
openaire +1 more source
KOREAN SOCIETY AND PUBLIC ADMINISTRACTION, 2023
Kyunghee Lee, Kwangseon Hwang
openaire +1 more source
Kyunghee Lee, Kwangseon Hwang
openaire +1 more source
Frontline: Working to include London's excluded populations
The Lancet, 2016openaire +2 more sources
Ethical Climate at the Frontline: A Meta-Analytic Evaluation
Journal of Service Research, 2020Scott B Friend +2 more
exaly

